<DOC>
	<DOCNO>NCT01688570</DOCNO>
	<brief_summary>While baseline weakness clearly important factor contributes disability post stroke , neuromuscular fatigue ( acute reduction force production ) paretic musculature likely compound strength deficit exacerbate disability . The propose study aim improve understand mechanism neuromuscular fatigue people post stroke order optimize strength training . In healthy individual , central ( neural ) peripheral ( muscle ) factor determinant neuromuscular fatigue , preliminary data laboratory suggest great contribution central component neuromuscular fatigue paretic musculature . Although cortical pathway clearly disrupt post stroke , likely brainstem pathway , know neuromodulatory effect spinal motor circuitry , involve sustain force paretic leg , compare non-paretic control leg . Therefore , purpose proposal examine role descend neuromodulatory pathway brainstem neuromuscular fatigue post stroke ( Aim 1 ) correlate brainstem-related change neuromuscular fatigue walk function ( Aim 2 ) . The investigator propose stroke survivor ' decrease capability sustain force overtime result diminish ability spinal motoneuron respond brainstem neuromodulatory input ( serotonin ( 5-HT ) norepinephrine ( NE ) ) . Aim 1 quantify stroke-related decrease motor output sensitivity 5-HT NE reuptake inhibitor ( SNRI ) , serotonin antagonist , placebo sub-maximal intermittent fatigue knee extension contraction . If motoneuron desensitize descend monoamine chronic stroke patient , less sensitive effect drug increase monoamine level . The investigator predict response SNRI serotonin antagonist , paretic leg show le change time task failure small reduction strength compare non-paretic control leg . For Aim 2 , investigator predict stroke subject high walk function demonstrate great fatigue-related change response SNRI . This proposal adopt innovative model motor impairment post stroke include role subcortical structure neuromuscular fatigue .</brief_summary>
	<brief_title>Mechanisms Neuromuscular Fatigue Post Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Duloxetine Hydrochloride</mesh_term>
	<mesh_term>Cyproheptadine</mesh_term>
	<criteria>General least 18 year age Cognitively able give inform consent Stroke ≥ 6 month post diagnosis unilateral cortical stroke residual leg paresis General chronic low back hip pain major psychiatric disorder ( e.g . depression substance abuse head trauma neurodegenerative disorder uncontrolled medical disorder ( e.g . hypertension ) take medication supplement ( e.g . St. John 's Wort ) 5HT NE mechanism action ( include Monoamine oxidase inhibitor ( MAO ) inhibitor ) narrow angle glaucoma chronic liver kidney disorder Stroke history multiple stroke people unable follow 2 step command people walk ≥ 10 ft without physical assistance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>neuromuscular fatigue</keyword>
	<keyword>motor impairment</keyword>
</DOC>